BIOSIMILARS PORTAL
Main
Gowlings Expertise
Gowlings Professionals
Policy Positions
Presentations & Articles
Life Sciences & Law Current Issues 2011/12
SEBs: Are We Ready?
LINKS
CANADA
Health Canada
Pricing / Reimbursement
Legislation, Regulations & Guidances
OMNITROPE
UNITED STATES
Food & Drug Administration
Legislation, Regulations & Guidances
EUROPE
Legislation, Regulations & Guidances
INTERNATIONAL/OTHER COUNTRIES
Legislation, Regulations and Guidances
Legislation, Regulations & Guidances (Canada)
Legislation & Regulations
Patent Act
Patented Medicines (Notice of Compliance) Regulations
Food and Drugs Act
Food and Drug Regulations
Guidances
Guidance For Sponsors: Information and Submission Requirements for Subsequent Entry Biologics (SEBs)
- (March 5, 2010)
Data Protection under C.08.004.1 of the Food and Drug Regulations
- (March 8, 2010)
Patented Medicines (Notice of Compliance) Regulations
- (March 8, 2010)
Draft Guidance document: for Sponsors of Subsequent Entry Biologics (SEBs)
- (March 27, 2009)
Draft amendments to Health Canada Guidance re: Patented Medicines (Notice of Compliance) Regulations
- (March 27, 2009)
Draft amendments to Health Canada Guidance re: Data Protection Regulations
- (March 27, 2009)
Visit our presentations page for more information
Montréal
Ottawa
Kanata
Toronto
Hamilton
Waterloo Region
Calgary
Vancouver
Moscow
London
Privacy
|
Terms of Use
© 2010 Gowling Lafleur Henderson LLP. All rights reserved.